Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives.
Basic Information
ID: ALA4177629
Journal: Bioorg Med Chem Lett
Title: Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives.
Authors: Simon L, Abdul Salam AA, Madan Kumar S, Shilpa T, Srinivasan KK, Byrappa K.
Abstract: A series of 3-Benzylchroman-4-ones were synthesized and screened for anticancer activity by MTT assay. The compounds were evaluated against two cancerous cell lines BT549 (human breast carcinoma), HeLa (human cervical carcinoma), and one noncancerous cell line vero (normal kidney epithelial cells). 3b was found to be the most active molecule against BT549 cells (IC50 = 20.1 µM) and 3h against HeLa cells (IC50 = 20.45 µM). 3b also exhibited moderate activity against HeLa cells (IC50 = 42.8 µM). The molecular structures of 3h and 3i were solved by single crystal X-ray crystallographic technique. Additionally, the molecular docking studies between the tumour suppressor protein p53 with the lead compound 3h, which exhibited better anticancer activity against HeLa cells was examined.
CiteXplore: 29074256
DOI: 10.1016/j.bmcl.2017.10.026
Patent ID: ┄